569 related articles for article (PubMed ID: 24141787)
21. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
[TBL] [Abstract][Full Text] [Related]
22. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
23. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
[TBL] [Abstract][Full Text] [Related]
24. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
[TBL] [Abstract][Full Text] [Related]
25. Gene of the month: PALB2.
Hamdan O; Nowak KM
J Clin Pathol; 2023 Feb; 76(2):73-75. PubMed ID: 36600573
[TBL] [Abstract][Full Text] [Related]
26. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
[TBL] [Abstract][Full Text] [Related]
27. Cancer-causing mutations in the tumor suppressor PALB2 reveal a novel cancer mechanism using a hidden nuclear export signal in the WD40 repeat motif.
Pauty J; Couturier AM; Rodrigue A; Caron MC; Coulombe Y; Dellaire G; Masson JY
Nucleic Acids Res; 2017 Mar; 45(5):2644-2657. PubMed ID: 28158555
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks.
Buisson R; Niraj J; Pauty J; Maity R; Zhao W; Coulombe Y; Sung P; Masson JY
Cell Rep; 2014 Feb; 6(3):553-64. PubMed ID: 24485656
[TBL] [Abstract][Full Text] [Related]
29. Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.
Anantha RW; Alcivar AL; Ma J; Cai H; Simhadri S; Ule J; König J; Xia B
PLoS One; 2013; 8(4):e61368. PubMed ID: 23585894
[TBL] [Abstract][Full Text] [Related]
30. MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks.
Hayakawa T; Zhang F; Hayakawa N; Ohtani Y; Shinmyozu K; Nakayama J; Andreassen PR
J Cell Sci; 2010 Apr; 123(Pt 7):1124-30. PubMed ID: 20332121
[TBL] [Abstract][Full Text] [Related]
31. BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.
Foo TK; Xia B
Cancer Res; 2022 Sep; 82(18):3191-3197. PubMed ID: 35819255
[TBL] [Abstract][Full Text] [Related]
32. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
33. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
Cousineau I; Belmaaza A
Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
[TBL] [Abstract][Full Text] [Related]
34. Assessment of PALB2 as a candidate melanoma susceptibility gene.
Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
[TBL] [Abstract][Full Text] [Related]
35. Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer.
Toh MR; Low CE; Chong ST; Chan SH; Ishak NDB; Courtney E; Kolinjivadi AM; Rodrigue A; Masson JY; Ngeow J
Fam Cancer; 2020 Apr; 19(2):123-131. PubMed ID: 32048105
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
Hamid AB; Frank LE; Bouley RA; Petreaca RC
PLoS One; 2022; 17(9):e0273736. PubMed ID: 36107942
[TBL] [Abstract][Full Text] [Related]
37. A mechanism for the suppression of homologous recombination in G1 cells.
Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G; Xia B; Peter M; Durocher D
Nature; 2015 Dec; 528(7582):422-6. PubMed ID: 26649820
[TBL] [Abstract][Full Text] [Related]
38. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
39. ATM/ATR-mediated phosphorylation of PALB2 promotes RAD51 function.
Ahlskog JK; Larsen BD; Achanta K; Sørensen CS
EMBO Rep; 2016 May; 17(5):671-81. PubMed ID: 27113759
[TBL] [Abstract][Full Text] [Related]
40. Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.
Shahid T; Soroka J; Kong E; Malivert L; McIlwraith MJ; Pape T; West SC; Zhang X
Nat Struct Mol Biol; 2014 Nov; 21(11):962-968. PubMed ID: 25282148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
